Identification of Bone Marrow Cell Subpopulations Associated with Improved Functional Outcomes in Patients with Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial

In the current study, we sought to identify bone marrow-derived mononuclear cell (BM-MNC) subpopulations associated with a combined improvement in left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV), and maximal oxygen consumption (VO 2 max) in patients with chron...

Full description

Bibliographic Details
Main Authors: Doris A. Taylor, Emerson C. Perin, James T. Willerson, Claudia Zierold, Micheline Resende, Marjorie Carlson, Belinda Nestor, Elizabeth Wise, Aaron Orozco, Carl J. Pepine, Timothy D. Henry, Stephen G. Ellis, David X. M. Zhao, Jay H. Traverse, John P. Cooke, Robert C. Schutt, Aruni Bhatnagar, Maria B. Grant, Dejian Lai, Brian H. Johnstone, Shelly L. Sayre, Lem Moyé, Ray F. Ebert, Roberto Bolli, Robert D. Simari
Format: Article
Language:English
Published: SAGE Publishing 2016-09-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368915X689901
_version_ 1828886584418631680
author Doris A. Taylor
Emerson C. Perin
James T. Willerson
Claudia Zierold
Micheline Resende
Marjorie Carlson
Belinda Nestor
Elizabeth Wise
Aaron Orozco
Carl J. Pepine
Timothy D. Henry
Stephen G. Ellis
David X. M. Zhao
Jay H. Traverse
John P. Cooke
Robert C. Schutt
Aruni Bhatnagar
Maria B. Grant
Dejian Lai
Brian H. Johnstone
Shelly L. Sayre
Lem Moyé
Ray F. Ebert
Roberto Bolli
Robert D. Simari
author_facet Doris A. Taylor
Emerson C. Perin
James T. Willerson
Claudia Zierold
Micheline Resende
Marjorie Carlson
Belinda Nestor
Elizabeth Wise
Aaron Orozco
Carl J. Pepine
Timothy D. Henry
Stephen G. Ellis
David X. M. Zhao
Jay H. Traverse
John P. Cooke
Robert C. Schutt
Aruni Bhatnagar
Maria B. Grant
Dejian Lai
Brian H. Johnstone
Shelly L. Sayre
Lem Moyé
Ray F. Ebert
Roberto Bolli
Robert D. Simari
author_sort Doris A. Taylor
collection DOAJ
description In the current study, we sought to identify bone marrow-derived mononuclear cell (BM-MNC) subpopulations associated with a combined improvement in left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV), and maximal oxygen consumption (VO 2 max) in patients with chronic ischemic cardiomyopathy 6 months after receiving transendocardial injections of autologous BM-MNCs or placebo. For this prospectively planned analysis, we conducted an embedded cohort study comprising 78 patients from the FOCUS-Cardiovascular Cell Therapy Research Network (CCTRN) trial. Baseline BM-MNC immunophenotypes and progenitor cell activity were determined by flow cytometry and colony-forming assays, respectively. Previously stable patients who demonstrated improvement in LVEF, LVESV, and VO 2 max during the 6-month course of the FOCUS-CCTRN study (group 1, n = 17) were compared to those who showed no change or worsened in one to three of these endpoints (group 2, n = 61) and to a subset of patients from group 2 who declined in all three functional endpoints (group 2A, n = 11). Group 1 had higher frequencies of B-cell and CXCR4 + BM-MNC subpopulations at study baseline than group 2 or 2A. Furthermore, patients in group 1 had fewer endothelial colony-forming cells and monocytes/macrophages in their bone marrow than those in group 2A. To our knowledge, this is the first study to show that in patients with ischemic cardiomyopathy, certain bone marrow-derived cell subsets are associated with improvement in LVEF, LVESV, and VO 2 max at 6 months. These results suggest that the presence of both progenitor and immune cell populations in the bone marrow may influence the natural history of chronic ischemic cardiomyopathy—even in stable patients. Thus, it may be important to consider the bone marrow composition and associated regenerative capacity of patients when assigning them to treatment groups and evaluating the results of cell therapy trials.
first_indexed 2024-12-13T11:48:24Z
format Article
id doaj.art-4cf4483e0be94e109821143e6091df9e
institution Directory Open Access Journal
issn 0963-6897
1555-3892
language English
last_indexed 2024-12-13T11:48:24Z
publishDate 2016-09-01
publisher SAGE Publishing
record_format Article
series Cell Transplantation
spelling doaj.art-4cf4483e0be94e109821143e6091df9e2022-12-21T23:47:27ZengSAGE PublishingCell Transplantation0963-68971555-38922016-09-012510.3727/096368915X689901Identification of Bone Marrow Cell Subpopulations Associated with Improved Functional Outcomes in Patients with Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN TrialDoris A. Taylor0Emerson C. Perin1James T. Willerson2Claudia Zierold3Micheline Resende4Marjorie Carlson5Belinda Nestor6Elizabeth Wise7Aaron Orozco8Carl J. Pepine9Timothy D. Henry10Stephen G. Ellis11David X. M. Zhao12Jay H. Traverse13John P. Cooke14Robert C. Schutt15Aruni Bhatnagar16Maria B. Grant17Dejian Lai18Brian H. Johnstone19Shelly L. Sayre20Lem Moyé21Ray F. Ebert22Roberto Bolli23Robert D. Simari24 Texas Heart Institute, CHI St. Luke's Health, Houston, TX, USATexas Heart Institute, CHI St. Luke's Health, Houston, TX, USATexas Heart Institute, CHI St. Luke's Health, Houston, TX, USAUniversity of Minnesota School of Medicine, Minneapolis, MN, USATexas Heart Institute, CHI St. Luke's Health, Houston, TX, USAUniversity of Minnesota School of Medicine, Minneapolis, MN, USATexas Heart Institute, CHI St. Luke's Health, Houston, TX, USAUniversity of Florida College of Medicine, Gainesville, FL, USATexas Heart Institute, CHI St. Luke's Health, Houston, TX, USAUniversity of Florida College of Medicine, Gainesville, FL, USAMinneapolis Heart Institute Foundation at Abbott, Minneapolis, MN, USACleveland Clinic Foundation, Cleveland, OH, USAWake Forest School of Medicine, Winston-Salem, NC, USAMinneapolis Heart Institute Foundation at Abbott, Minneapolis, MN, USAHouston Methodist Research Institute, Houston, TX, USAHouston Methodist Research Institute, Houston, TX, USAUniversity of Louisville, Louisville, KY, USAUniversity of Florida College of Medicine, Gainesville, FL, USAUniversity of Texas School of Public Health, Houston, TX, USAIndiana University School of Medicine, Indianapolis, IN, USAUniversity of Texas School of Public Health, Houston, TX, USAUniversity of Texas School of Public Health, Houston, TX, USANational Heart, Lung, and Blood Institute, Bethesda, MD, USAUniversity of Louisville, Louisville, KY, USAUniversity of Kansas School of Medicine, Kansas City, KS, USAIn the current study, we sought to identify bone marrow-derived mononuclear cell (BM-MNC) subpopulations associated with a combined improvement in left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV), and maximal oxygen consumption (VO 2 max) in patients with chronic ischemic cardiomyopathy 6 months after receiving transendocardial injections of autologous BM-MNCs or placebo. For this prospectively planned analysis, we conducted an embedded cohort study comprising 78 patients from the FOCUS-Cardiovascular Cell Therapy Research Network (CCTRN) trial. Baseline BM-MNC immunophenotypes and progenitor cell activity were determined by flow cytometry and colony-forming assays, respectively. Previously stable patients who demonstrated improvement in LVEF, LVESV, and VO 2 max during the 6-month course of the FOCUS-CCTRN study (group 1, n = 17) were compared to those who showed no change or worsened in one to three of these endpoints (group 2, n = 61) and to a subset of patients from group 2 who declined in all three functional endpoints (group 2A, n = 11). Group 1 had higher frequencies of B-cell and CXCR4 + BM-MNC subpopulations at study baseline than group 2 or 2A. Furthermore, patients in group 1 had fewer endothelial colony-forming cells and monocytes/macrophages in their bone marrow than those in group 2A. To our knowledge, this is the first study to show that in patients with ischemic cardiomyopathy, certain bone marrow-derived cell subsets are associated with improvement in LVEF, LVESV, and VO 2 max at 6 months. These results suggest that the presence of both progenitor and immune cell populations in the bone marrow may influence the natural history of chronic ischemic cardiomyopathy—even in stable patients. Thus, it may be important to consider the bone marrow composition and associated regenerative capacity of patients when assigning them to treatment groups and evaluating the results of cell therapy trials.https://doi.org/10.3727/096368915X689901
spellingShingle Doris A. Taylor
Emerson C. Perin
James T. Willerson
Claudia Zierold
Micheline Resende
Marjorie Carlson
Belinda Nestor
Elizabeth Wise
Aaron Orozco
Carl J. Pepine
Timothy D. Henry
Stephen G. Ellis
David X. M. Zhao
Jay H. Traverse
John P. Cooke
Robert C. Schutt
Aruni Bhatnagar
Maria B. Grant
Dejian Lai
Brian H. Johnstone
Shelly L. Sayre
Lem Moyé
Ray F. Ebert
Roberto Bolli
Robert D. Simari
Identification of Bone Marrow Cell Subpopulations Associated with Improved Functional Outcomes in Patients with Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial
Cell Transplantation
title Identification of Bone Marrow Cell Subpopulations Associated with Improved Functional Outcomes in Patients with Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial
title_full Identification of Bone Marrow Cell Subpopulations Associated with Improved Functional Outcomes in Patients with Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial
title_fullStr Identification of Bone Marrow Cell Subpopulations Associated with Improved Functional Outcomes in Patients with Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial
title_full_unstemmed Identification of Bone Marrow Cell Subpopulations Associated with Improved Functional Outcomes in Patients with Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial
title_short Identification of Bone Marrow Cell Subpopulations Associated with Improved Functional Outcomes in Patients with Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial
title_sort identification of bone marrow cell subpopulations associated with improved functional outcomes in patients with chronic left ventricular dysfunction an embedded cohort evaluation of the focus cctrn trial
url https://doi.org/10.3727/096368915X689901
work_keys_str_mv AT dorisataylor identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT emersoncperin identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT jamestwillerson identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT claudiazierold identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT michelineresende identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT marjoriecarlson identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT belindanestor identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT elizabethwise identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT aaronorozco identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT carljpepine identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT timothydhenry identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT stephengellis identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT davidxmzhao identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT jayhtraverse identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT johnpcooke identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT robertcschutt identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT arunibhatnagar identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT mariabgrant identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT dejianlai identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT brianhjohnstone identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT shellylsayre identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT lemmoye identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT rayfebert identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT robertobolli identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT robertdsimari identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial
AT identificationofbonemarrowcellsubpopulationsassociatedwithimprovedfunctionaloutcomesinpatientswithchronicleftventriculardysfunctionanembeddedcohortevaluationofthefocuscctrntrial